Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5R35
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,661
Award facts
- Contract value 100% obligated
- $10,661.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Wegovy (semaglutide) 1.7 mg/0.75 mL pen injections, with a contract ceiling value of $10,661.24 and an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal contracting relationships with the Defense Logistics Agency and serves critical medical procurement needs for military and veteran healthcare systems. The company's federal contract portfolio demonstrates capability across a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Wegovy represents a routine pharmaceutical supply transaction within the scope of AmerisourceBergen's established prime vendor relationship with DLA, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26F5R35?
SPE2DR26F5R35 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F5R35 worth?
The government has obligated $10,661 on SPE2DR26F5R35.
Is contract SPE2DR26F5R35 an order under another contract?
Yes. SPE2DR26F5R35 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5R35 competed?
The extent of competition for SPE2DR26F5R35 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award